Despite objections that 18 year olds should be treated like adults and allowed to smoke, local governments are trying to prevent the next generation of young adults from becoming victims of the tobacco industry. Last year Chicago banned the sale of all flavored tobacco products, which are marketed to attract young customers, within 500 feet of schools. In October of 2014, the city council just down the road in Evanston, Ill., joined a growing list of cities in banning tobacco sales to anyone under the age of 21.
In September of this year, the Drug Enforcement Administration (DEA) authorized pharmacies to accept unused prescription drugs from customers. Prescription drug misuse has been a huge problem in the United States.
The Food and Drug Administration (FDA) released a proposed regulation in April and solicited comments on how to regulate tobacco products that are subject to the Family Smoking Prevention and Tobacco Control Act in 2009. Up until now, many tobacco products such as dissolvable tobacco, cigars, cigarillos, hookah, e-cigarettes and pipe tobacco, were not subject to FDA regulation. The FDA is responsible for “regulating the manufacturing, marketing and distribution of tobacco products to protect the public health and to reduce tobacco use by minors.” The fact that many tobacco products have escaped FDA regulation until this time goes against their mission. It is vital that the FDA claim its power to regulate these products.
On June 19, New York Governor Andrew M. Cuomo and legislative leaders reached a deal to create a medical marijuana program for New York. Cuomo says that the agreement “strikes the right balance” between making marijuana available for people who have serious health conditions and protecting public health and safety at the same time. We share Cuomo’s concerns about the balance of making treatment available for people who need it while prohibiting smoked marijuana.
In recent weeks news has broken that President Obama is considering granting clemency to hundreds of thousands of non-violent drug offenders incarcerated in the United States. An act of this magnitude is long overdue and is a step in the right direction when it comes to dealing with our nation’s policy toward drug offenders.
The Mental Health Parity and Addiction Equity Act (MHPAEA) requires that if a health plan offers addiction treatment benefits, the plan must offer coverage at the same level as coverage for medical and surgical benefits. This guide will help you naviagte the new rules.
It’s no secret that quitting smoking is difficult. While effective treatments (medications and counseling or other behavioral therapies known as smoking cessation treatments) can help smokers quit, cost can limit smokers’ use of these services.
CASAColumbia recently sat down with Kevin Sabet, Ph.D., Director of the Drug Policy Institute at the University of Florida and Founder of Project SAM (Smart Approaches to Marijuana), to talk about how the U.S. can create smart and effective marijuana policy.
It’s no secret that addiction treatment is cost-prohibitive for many of the people that desperately need it. Learn how insurance coverage will be impacted by the new health care laws.
Today, the National Institute on Drug Abuse (NIDA) released their annual Monitoring the Future report, which measures substance use and attitudes among the nation’s 8th-, 10th- and 12th-graders. The 2013 report showed continued progress in the decline of some forms of substance use among teens, namely with alcohol, cigarettes and prescription opioids. However, according to the report, while the use of these substances has declined, teen use of marijuana, prescription stimulants and other tobacco/nicotine products has increased.
Newsletter Additional Information
Thank you for subscribing
This information will be used to better customize your experience and help inform future tools and features on our website.